Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, March 4, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Life Sciences
Klick Health Recognized as a Best Workplace for Women for 6th Year in a Row
Life Sciences Times
-
March 23, 2021
0
Medtech
Mercy Iowa City selects Allscripts SunriseTM
Life Sciences Times
-
March 22, 2021
0
Venture Capital
Komodo Health Secures $220M in Funding Led by Tiger Global
Life Sciences Times
-
March 22, 2021
0
Biotech
Call for Locally Sourced Medical Devices Answered by Vonco Products
Life Sciences Times
-
March 18, 2021
0
Pharma
Delix Therapeutics Names Mark Rus as Chief Executive Officer
Life Sciences Times
-
March 18, 2021
0
Biotech
Waters new BioAccord System Boosts Innovator and Biosimilar Drug Development
Life Sciences Times
-
March 18, 2021
0
Real Estate
Lendlease and Ivanhoé Cambridge to Develop World-Class Life Science Project in Boston, Retain SGA to Design the Building
Life Sciences Times
-
March 18, 2021
0
Pharma
FSD Pharma Enters into License Agreement to Develop Veterinary Drugs for the Treatment of Dogs and Cats
Life Sciences Times
-
March 17, 2021
0
Life Sciences
Life Sciences Industry Looks to Digital Innovation to Help Navigate the Pandemic and Beyond
Life Sciences Times
-
March 17, 2021
0
Pharma
PerkinElmer Further Expands Capabilities in Biologics Drug Discovery
Life Sciences Times
-
March 17, 2021
0
1
...
775
776
777
...
805
Page 776 of 805
TOP AUTHORS
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Most Read
Mobile Heartbeat Expands Banyan Platform Integration With Microsoft Teams to Improve Enterprise Communication
March 3, 2026
Syntis Bio Doses First Patient in Phase 1/1b Trial of Oral Obesity Drug SYNT-101, Expands Leadership Team
March 3, 2026
Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases
March 3, 2026
Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion
March 3, 2026